Patient info

Magnesium Kora Healthcare 4 mmol (97 mg) tablets – patient leaflet, side effects, dosage

Updated:
Medicine strength:
4 mmol
Similar medicines:

Patient leaflet - Magnesium Kora Healthcare 4 mmol (97 mg) tablets

1. What Magnesium Kora Healthcare is and what it is used for

Magnesium Kora Healthcare contains the active ingredient magnesium citrate nonahydrate equivalent to 97.2 mg (4 mmol) of magnesium.

Magnesium Kora Healthcare is intended for the treatment and prevention of magnesium deficiency in adults, adolescents and children aged from 12 years. Magnesium is an essential mineral which is particularly important in nerve and muscle function in addition to other activities within the body.

You must talk to a doctor if you do not feel better or if you feel worse after taking this medicine.

Magnesium Kora Healthcare is not intended for the treatment of either severe magnesium loss (blood magnesium level is less than 0.4mmol/L) or severe symptoms. Treatment with oral magnesium can begin when blood magnesium levels rise above 0.4mmol/L or when the severe symptoms are no longer present.

2. What you need to know before you

take Magnesium Kora Healthcare Do not take Magnesium Kora Healthcare

  • if you are allergic to magnesium citrate nonahydrate or

    any of the other ingredients of this medicine (listed in section 6).

  • if you have severe kidney problems

Warnings and precautions

Talk to your doctor or pharmacist before taking Magnesium Kora Healthcare:

  • if you suffer from kidney problems.
  • if you suffer from heart problems.
  • If you have confirmed magnesium deficiency as you may

    also have low calcium and low potassium levels. • If you suffer any side effects such as diarrhoea, treatment

    should be temporarily interrupted and can be restarted after improvement and /or elimination of the symptoms with a reduced dosage.

  • If you have switched from another magnesium medicine

    to ensure that treatment with Magnesium Kora Healthcare does not make you feel unwell and that you can continue to receive the correct dose of magnesium.

Other medicines and Magnesium Kora Healthcare

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is because Magnesium Kora Healthcare can affect the way some other medicines work. Also, some other medicines can affect the way Magnesium Kora Healthcare works.

In particular, you must allow a time interval of 2-3 hours between taking Magnesium Kora Healthcare and the following medicines.

  • Cellulose sodium phosphate, used to prevent kidney stones
  • EDTA, used in hospital for high calcium levels • Fluorides, used for preventing tooth decay • Tetracycline, an antibiotic to treat infections

In order to avoid reduced absorption, magnesium preparations should be taken 3 to 4 hours before or after taking the following medicines.

  • Nitrofurantoin, Nitroxoline, antibiotics to treat infections • Aminoquinolines, medicines to treat malaria • Quinidine and quinidine derivatives, medicines to treat heart rhythm disorders
  • Penicillamine, medicine used to treat severe rheumatoid arthritis and used in Wilson's disease
  • Iron, to treat anemia
  • Bisphosphonates, to treat osteoporosis
  • Eltrombopag, to correct bleeding deficiency

The following medicines may cause magnesium deficiency. Your doctor may decide to adjust your daily dose of magnesium.

  • Aminoglycosides, antibiotics used to treat infections e.g.

    gentamicin, tobramycin and amikacin

  • Certain medicines used to treat cancer such as cisplatin, carboplatin and EGF-receptor antagonists such as cetuximab, erlotinib and panitumumab. • Ciclosporins and Tacrolimus, medicines used to suppress the body’s immune system e.g. following an organ transplant
  • Water tablets (Diuretics), medicines used to treat blood pressure or heart failure e.g. thiazide, furosemide • Proton Pump Inhibitors, medicines used to treat high acid in the stomach or oesophagus. e.g. omeprazole, esomeprazole, lansoprazole, pantoprazole • VEGF-blockers such as bevacizumab
  • PD-1 inhibitors such as Nivolumab
  • Amphotericin B, antibiotic that fights fungal infections in the body
  • Rapamycin, medicine used to suppress the body’s immune system e.g. following an organ transplant • Pentamidine, medicine to treat infections such as pneumonia
  • Foscarnet, an antiviral medication

Disorders that may influence the level of magnesium in the body include:

  • diabetes
  • over-active thyroid
  • too much aldosterone produced by the adrenal glands

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Magnesium Kora Healthcare can be used during pregnancy and during breast-feeding without concerns.

Based on long-term experience, no effects of magnesium on male and female fertility are anticipated.

Package leaflet: Information for the user

Magnesium Kora Healthcare 4 mmol (97 mg) Tablets magnesium

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,

    even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

    See section 4.

Product:

Magnesium Kora Healthcare 4mmol 97mg Tablets-EngUK

Origination:

24/11/20

Update: 26/01/21 Update: 08/02/21 Update: 08/07/21 Update: 06/09/21 Update: 13/09/21 Update: 01/04/22

Registration:
Spec Code: 71-02

KORA

HEALTHCARE Client:

Dimensions: 170x295mmDate:
Typefont: Arial 8 point

1607956B 170 mm

12 mm

12 mm

Driving and using machines

Magnesium Kora Healthcare has no or negligible influence on the ability to drive and use machines.

3. How to take Magnesium Kora Healthcare

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Renal patients:

Do not take Magnesium Kora Healthcare if you have severe renal failure.

No change to the recommended dose is required if you have mild to moderate renal failure.

The blood magnesium levels of children and adolescents (12 to 18 years) and renal patients need to be monitored at regular intervals.

The duration of magnesium supplementation will depend upon the clinical needs of each patient.

If you take more Magnesium Kora Healthcare than you should

No side effects are expected in cases where the kidneys are fully functioning. Any excessive amount of magnesium will be excreted through your kidneys.

If you have taken more of this medicine than directed, or if a person with severe kidney problems, or if a child accidentally has taken this medicine, please contact your doctor or local hospital casualty department for judgement of the risk and advice. Symptoms may include: light-headedness/dizziness, nausea, vomiting, drowsiness, shortness of breath and cardiac arrest.

If you forget to take Magnesium Kora Healthcare

Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Common (may affect up to 1 to 10 people): Soft stools or diarrhoea following high doses.

Very rare (may affect up to 1 in 10,000 people): Fatigue if Magnesium Kora Healthcare is used long-term.

If you get any side effects such as diarrhoea, you should discuss this with your doctor or a pharamcist. Your doctor may temporarily interrupt your treatment with Magnesium Kora Healthcare. After the symptoms improve your doctor may recommend that you restart treatment, with a reduced dosage.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can help provide more information on the safety of this medicine.

UNITED KINGDOM

Yellow Card Scheme

Website: http://www.mhra.gov.uk/yellowcard

or search for MHRA Yellow Card in the Google Play or Apple App Store

5. How to store Magnesium Kora Healthcare

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Magnesium Kora Healthcare contains

  • The active substance is magnesium. Each tablet contains magnesium citrate nonahydrate equivalent to 97.2 mg (4 mmol) magnesium
  • The other ingredients are mannitol (E421), copovidone, microcrystalline cellulose (E460(i)), magnesium stearate (E572).

What Magnesium Kora Healthcare looks like and contents of the pack

White, oblong tablet, marked with "MG" and "97" on either side of a score line on one side. Dimensions: 18 mm x 8.7 mm. Magnesium Kora Healthcare is available in packs of 60 or 100 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Kora Corporation Ltd t/a Kora Healthcare

20 Harcourt Street,

Dublin 2,

D02 H364,

Ireland

Manufacturer

Lusomedicamenta Sociedade Tecnica Farmaceutica, S.A. Estrada Consiglieri Pedroso, 69 - B, Queluz de Baixo, Barcarena,

2730-055, Portugal

This medicinal product is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

Ireland, Belgium, Netherlands Magmedi 97 mg tablets United Kingdom (Northern Ireland) Magnesium Kora

Healthcare 4 mmol (97 mg) tablets

This leaflet was last revised in

March 2022

Directions for use:

Tablets for oral use.

The tablet may be broken in half using the score line. The score line is only there to help you break the tablet if you have difficulty swallowing it whole, not to divide into equal parts.

Adults (over 18 years) 1-2 tablets 3 times daily (equal to 291.6 – 583.2 mg magnesium).

Use in children and adolescents

Children and Adolescents (12 to 18 years) 1 tablet 3 times daily (equal to 291.6 mg magnesium).

Magnesium Kora Healthcare tablets are not recommened for children less then 12 years. Other form(s) of this medicine may be more suitable for children under 12 years; ask your doctor or pharmacist.

As older patients may have reduced kidney function, dose adjustment may be necessary depending on their kidney function as detailed in section Renal patients below.

71-02

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 39972/0006

Last revision stated in the text: March 2022 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Magnesium Kora Healthcare 4 mmol (97 mg) tablets

Strength 4 mmol
Pharmaceutical form White, oblong tablet, marked with “Mg” and “97” on either side of a score line on one side. Dimensions: 18 mm x 8.7 mm. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
Excipients Mannitol (E421), Copovidone, Cellulose, Microcrystalline (E460(i)), Magnesium stearate (E572)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Mineral Supplements, magnesium citrate
  1. A Alimentary tract and metabolism drugs
    1. A12 Mineral supplements
      1. A12C Other mineral supplements
        1. A12CC Magnesium supplements, alimentary tract and metabolism
          1. A12CC04 magnesium citrate
Marketing authorisation PL 39972/0006 (first authorised 19 February 2021)
Marketing authorisation holder Kora Corporation Ltd t/a Kora Healthcare

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.